Multiple myeloma in the older adult: better prospects, more challenges. - Wikidata - wikimedia - TriplyDB

Multiple myeloma in the older adult: better prospects, more challenges.

Multiple myeloma in the older adult: better prospects, more challenges.

http://www.wikidata.org/entity/Q34031129

about

Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives Towards Stratified Medicine in Plasma Cell Myeloma Chemotherapy and Stem Cell Transplantation Increase p16INK4a Expression, a Biomarker of T-cell Aging.Risk of vertebral compression fractures in multiple myeloma patients: A finite-element study.Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study.Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.Autologous haematopoietic cell transplantation in elderly patients with multiple myeloma.ADP-ribosylation factor 1 (ARF1) takes part in cell proliferation and cell adhesion-mediated drug resistance (CAM-DR).Recent progress in relapsed multiple myeloma therapy: implications for treatment decisions.Management of Elderly Patients with Plasma Cell Myeloma.Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations.Future distribution of multiple myeloma in the United States by sex, age, and race/ethnicity.Guidelines for screening and management of late and long-term consequences of myeloma and its treatment.Down-regulation of long non-coding RNA MALAT1 by RNA interference inhibits proliferation and induces apoptosis in multiple myeloma.Low-dose lenalidomide and dexamethasone combination treatment in elderly patients with relapsed and refractory multiple myeloma.Phase II study of bendamustine, bortezomib and dexamethasone (BBD) in the first-line treatment of patients with multiple myeloma who are not candidates for high dose chemotherapy.Incidence and survival of hematological cancers among adults ages ≥75 years.Once-Weekly 1.6 mg/m2 Bortezomib BCD Regimen in Elderly Patients with Newly Diagnosed Multiple Myeloma Who are Unfit for Standard Dose Chemotherapy.A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol.

P2860

Q26799104-E5E6B1A7-E806-4679-9D22-C91C8CC0912B Q28074994-0506AD34-6836-454B-89BD-924AFFC330A0 Q37309695-ABA35185-B637-4ED4-8AFE-676C4758F3A0 Q37606354-04F70A10-6C43-4779-BE28-21D1DA90BC37 Q38385471-C9CEE861-8489-49CE-BBB3-34E2E33FE48C Q38389362-B776551F-A66B-4DE5-92E2-EE14EDD0B404 Q38554884-8BB955AE-6788-4A46-AD90-5A92B82C4B2C Q38714809-CECE56B6-65D5-45A9-865E-D68C21BB2D2A Q38757067-AE248F86-AA6E-4200-B355-A87B3487BE58 Q39001325-E9666011-4F46-4BA9-A931-EBA64BF05A35 Q41602673-0845EEED-DC1D-417D-B995-079DDE602C0B Q43096798-F4923849-4A9D-49E3-854B-FCA0A35D6DF2 Q47587127-1C2BBB84-A06C-4E18-85AD-C3D5CD28D3CF Q48196873-D51AABBB-4920-4ECA-936E-C704C17B7B45 Q51795374-85AE1B23-D1B8-4A6D-81E6-72A818E6D326 Q52911976-D27C62F3-32C6-4104-9EA9-636CB237F638 Q54342150-B5FA64EA-DAFD-422C-A8EC-4ED0CEE1886F Q54970050-6E5AFFE4-2B64-4162-86E2-B79DE8A1D9DB Q55431025-75DE05E3-87F3-4FCB-893B-6389ADAF29FF

P2860

Multiple myeloma in the older adult: better prospects, more challenges.

http://www.wikidata.org/entity/Q34031129

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Multiple myeloma in the older adult: better prospects, more challenges.

@ast

Multiple myeloma in the older adult: better prospects, more challenges.

@en

Multiple myeloma in the older adult: better prospects, more challenges.

@nl

type

label

Multiple myeloma in the older adult: better prospects, more challenges.

@ast

Multiple myeloma in the older adult: better prospects, more challenges.

@en

Multiple myeloma in the older adult: better prospects, more challenges.

@nl

prefLabel

Multiple myeloma in the older adult: better prospects, more challenges.

@ast

Multiple myeloma in the older adult: better prospects, more challenges.

@en

Multiple myeloma in the older adult: better prospects, more challenges.

@nl

P1433

Q34031129-9F4D45D4-E5F7-4570-A08A-4B3BC068CDE3

P1476

Q34031129-A6F3E072-A110-4481-BFC5-7002827B2495

P2093

Q34031129-95029A27-266D-4459-B646-5BAF905400A4

Q34031129-A3E8F523-36D0-4B21-9AC4-1B48429DCE03

Q34031129-CAEE5BE9-55BC-4267-ADAE-3950F326D86C

P2860

Q34031129-01B3F92E-8FFB-467D-A496-07B1AD751112

Q34031129-01D45E1B-9D50-484F-8EE7-2DCA200B1C8C

Q34031129-01E3CF93-B547-40CF-A60E-724FFCDF85EF

Q34031129-11502D6F-750B-4BA3-A704-4266498D8D06

Q34031129-15502BAD-FB87-4081-A5FF-0A41189D18D1

Q34031129-16BF5062-938D-49C9-BF9B-287702CF3935

Q34031129-18AC0720-B3E3-4CB0-A9C2-3557DA1343A7

Q34031129-1A8A2D75-EC45-4DBE-90E5-D224B4EF8B45

Q34031129-206BC7E0-C6FA-44F8-BF9F-87188F447DA9

Q34031129-20C4A770-692C-4430-B0F6-DBBAFB2D1EF5

P304

Q34031129-956A269F-37B7-42D5-9217-3AE7A27C6914

P31

Q34031129-CBF4B452-9684-4EE1-99DC-D67BBA968ECB

P356

Q34031129-391B3EE3-E434-4F56-B023-802AA29AA421

P407

Q34031129-40EEF390-A20B-40D8-8193-F09F155EB593

P433

Q34031129-DD93AA08-B03A-4612-84F9-D3AF16A6FF2E

P478

Q34031129-81880E47-2754-4CB5-A56F-4F2F36F72E49

P577

Q34031129-C2A12625-1290-401E-8904-FD663A302B58

P698

Q34031129-1B91FF07-A240-40CD-91F3-2E7D8497846D

P932

Q34031129-F771B7B5-0017-42AE-BACB-CF9A1CE17A68

P356

JCO.2014.55.1028

P1433

Journal of Clinical Oncology

P1476

Multiple myeloma in the older adult: better prospects, more challenges.

@en

P2093

Ashley Rosko

http://www.w3.org/2001/XMLSchema#string

Sascha A Tuchman

http://www.w3.org/2001/XMLSchema#string

Tanya M Wildes

http://www.w3.org/2001/XMLSchema#string

P2860

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials.

ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma.

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma

Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic.

Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials.

Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data.

Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged ≥ 65 years treated with melphalan, prednisone and lenalidomide followed by lenalidomide maintenance: results of a randomized trial.

P304

2531-2540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2014.55.1028

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25071143

http://www.w3.org/2001/XMLSchema#string

P932

4129503

http://www.w3.org/2001/XMLSchema#string